Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site
Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.
The development and manufacturing site will be leveraged as a CDMO by Rentschler Biopharma.
The closing of the transaction is subject to the prior satisfaction or waiver of certain closing conditions.
Financial terms of the transaction were not disclosed.